About
High-quality human biological samples are critical for advancing drug discovery, diagnostics, and precision medicine. In this webinar, three experts discuss best practices for ensuring specimen integrity, leveraging biobanking for oncology breakthroughs, and enriching clinical data for translational research.

Key Determinants for Specimen Quality: Best practices for accurate results

Cathie Miller, PhD
Senior Director of Product Management, BioIVT

Advancements in drug discovery and diagnostics hinge on the quality of human biological specimens (HBS), as poor-quality specimens can undermine research validity, inflate costs, and delay progress. High-quality biospecimens are essential for reliable studies, clinical trials, and innovative treatments, with rigorous quality control, ethical compliance, and robust biobanking frameworks being non-negotiable. Providers like BioIVT exemplify industry standards through stringent quality measures, regulatory adherence, and diverse donor networks, ensuring specimens meet research needs. For example, BioIVT supports Antibody-Drug Conjugate (ADC) development by offering Ki67 staining on biospecimens, providing pre-stained blocks and custom screening projects to accelerate research. By partnering with trusted providers, researchers can mitigate risks, uphold scientific integrity, and accelerate breakthroughs in areas like liquid biopsy and targeted therapies.

How High-Quality Biospecimens Drive Oncology Breakthroughs

Katharina Krohn
Senior Director, Global Biobanks, Crown Bioscience

This presentation, led by Katharina Krohn, dives into the critical role of biospecimens in enabling clinically relevant oncology research. It covers best practices in biospecimen collection, storage, and quality assurance, including ISO-certified protocols and Crown Bioscience’s global biobank capabilities. We discuss how superior sample quality directly impacts research outcomes, showcasing real-world data from internal studies—such as the long-term stability of plasma cfDNA—and quantifying the financial benefits of low failure rates. This webinar will help researchers reduce variability, improve reproducibility, and unlock deeper biological insights for precision medicine.

From Clinic to Discovery: Maximizing Standard-of-Care Biospecimens

Meredith Osborn
Associate Director Product Management, Discovery Life Sciences

Precision medicine breakthroughs rely on uncovering and exploring novel biomarkers and mechanisms of action. Yet the reality is many patients aren’t getting tested for established biomarkers—let alone emerging research candidates. Discovery Life Sciences will discuss the limitations of standard of care data and share proven strategies for delivering research-ready samples enriched with meaningful data.
When
Tuesday, October 21, 2025 · 11:00 a.m. Eastern Time (US & Canada) (GMT -4:00)
Presenters
1758834123-d74985e1341c32cb
Cathie G. Miller, PhD
Senior Director of Product Management, BioIVT
With a career that spans over 20 years at the bench, as well as a Director and a Global Product Manager, all involving the use of biospecimens in the fields of cancer, immunology and virology, Cathie is now Senior Director of Product Marketing, Personalized Medicine, at BioIVT.
1758834172-7b13b5fce7340310
Katharina Krohn
Senior Director, Global Biobanks, Crown Bioscience
Katharina Krohn leads Crown Bioscience’s Surgical Biobanking business including all global operations from the various clinical networks. Before joining the company, she was employed at the Center for Biochemistry and Molecular Cell Biology at the University Medical Center in Göttingen. Her work focused on molecular biology and protein biochemistry and protein biochemical experiments on the expression and purification of recombinant proteins. Katharina started within the pathology department as a technician in 2014, responsible for the coordination and execution of customer projects. Her first activities as a biobank manager began in 2016 resulting in the founding of today's Liquid Biopsy Biobank.
1750179347-58285b8d08dbead1
Meredith Osborn
Associate Director Product Management, Discovery Life Sciences
Meredith Osborn, MS, is a biospecimen expert with over 15 years of experience in FFPE biobanking and other biospecimen solutions. As Associate Director of Product Management, she leads strategic initiatives to develop innovative products, meet research needs, and drive thought leadership in the field.
Reserve Your Spot
First Name*
Last Name*
Email Address*
Country / Region*
Job Title*
Job Level*
Organization / Company*
Organization Type*
utm_bmcr_source
Registration Terms
This event is hosted by Scientist.com. By registering, you acknowledge that your personal data will be processed by Scientist.com in accordance with their privacy policy. You agree to receive email communication from Scientist.com about this webinar and other programs of similar nature. Also, you acknowledge that your data will be processed by the Sponsors of this series in accordance with their privacy policies. You may receive email communication from the Sponsors about this webinar and programs of similar interest. You can withdraw your consent at any time from these communications.
To review the list of Sponsors and associated privacy policies, click here.
✓ Yes, I consent to the registration terms.*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.
Powered by BigMarker